The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma
- PMID: 39042207
- DOI: 10.1007/s00428-024-03873-x
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma
Abstract
Many researchers have focused on the role of the autonomic nervous system in the tumor microenvironment. Autonomic nerves include the sympathetic and parasympathetic nerves, which are known to induce cancer growth and metastasis. However, in salivary duct carcinoma (SDC), a rare and highly malignant tumor, the issue should be investigated from both biological and therapeutic perspectives. We explored the clinicopathological and prognostic implications of the autonomic nerves in 129 SDCs. Immunohistochemistry was performed to determine the nature of each nerve using antibodies against S100, tyrosine hydroxylase (TH) as a sympathetic marker, and vesicular acetylcholine transporter (VAChT) as a parasympathetic marker. The area of each marker-positive nerve was digitized and evaluated quantitatively. Double immunofluorescence for TH and VAChT was performed in selected cases. The expression of the secreted neurotrophins was also examined. S100-positive nerves were present in the cancer tissue in 94 of 129 cases (72.9%). Among them, TH-positive sympathetic nerves and/or VAChT-positive parasympathetic nerves were identified in 92 cases (97.9%), and 59 cases (62.8%) had TH/VAChT-co-expressing nerves. Double immunofluorescence revealed a mosaic pattern of sympathetic and parasympathetic fibers in co-expressing nerve bundles. The presence of autonomic nerves, regardless of their area, was significantly associated with aggressive histological features, advanced T/N classification, and a poor prognosis, with shorter disease-free and overall survival. There was an association between some tumor immune microenvironment-related markers and the autonomic nerve status, but not the latter and the secreted neurotrophin expression. This study suggests that autonomic nerves might play a role in the progression of SDC.
Keywords: Autonomic nerve; Cancer neuroscience; Parasympathetic nerve; Salivary duct carcinoma; Sympathetic nerve; Tumor microenvironment.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinoma.Thorac Cancer. 2016 Sep;7(5):588-598. doi: 10.1111/1759-7714.12374. Epub 2016 Jul 12. Thorac Cancer. 2016. PMID: 27766778 Free PMC article.
-
The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities.Theranostics. 2020 Mar 15;10(10):4383-4394. doi: 10.7150/thno.42986. eCollection 2020. Theranostics. 2020. PMID: 32292502 Free PMC article.
-
Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma.Pathol Res Pract. 2021 Dec;228:153678. doi: 10.1016/j.prp.2021.153678. Epub 2021 Oct 29. Pathol Res Pract. 2021. PMID: 34781210
-
The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma.Ann Diagn Pathol. 2021 Feb;50:151673. doi: 10.1016/j.anndiagpath.2020.151673. Epub 2020 Nov 23. Ann Diagn Pathol. 2021. PMID: 33248386 Review.
-
Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.Head Neck Pathol. 2017 Sep;11(3):288-294. doi: 10.1007/s12105-017-0798-x. Epub 2017 Mar 20. Head Neck Pathol. 2017. PMID: 28321773 Free PMC article. Review.
References
-
- Chiosea S, Agaimy A, Nagao T et al (2022) Salivary duct carcinoma. In: WHO Classification of Head and Neck Tumours (WHO Classification of tumours series, 5th ed.; vol.9). https://tumourclassification.iarc.who.int/chapters/52 . Accessed 5 February 2024
-
- Nakaguro M, Tada Y, Faquin WC et al (2020) Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol 128:693–703. https://doi.org/10.1002/cncy.22288 - DOI - PubMed - PMC
-
- Kawakita D, Nagao T, Takahashi H et al (2022) Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma. Ther Adv Med Oncol 14. https://doi.org/10.1177/17588359221119538
-
- Even C, Delord J-P, Price KA et al (2022) Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study. Eur J Cancer 171:259–268. https://doi.org/10.1016/j.ejca.2022.05.007 - DOI - PubMed
-
- Vos JL, Burman B, Jain S et al (2023) Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. Nat Med 29:3077–3089. https://doi.org/10.1038/s41591-023-02518-x - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical